Clinical trial
Clinical and Histological Study of a Novel Dermal Substitute, NovoSorb® BTM, Used in the Treatment of Full-thickness Skin Defects
NCT06255990 is registered in ClinicalTrials.gov with University Children's Hospital, Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Histological Study of a Novel Dermal Substitute, NovoSorb® BTM, Used in the Treatment of Full-thickness Skin Defects
- Lead sponsor
- University Children's Hospital, Zurich
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 15, 2024
- Completion date
- June 30, 2027
- Enrollment
- 42 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
skin transplantation